Please login to the form below

Not currently logged in
Email:
Password:

HRA Pharma UK

This page shows the latest HRA Pharma UK news and features for those working in and with pharma, biotech and healthcare.

Five companies breach ABPI code

Five companies breach ABPI code

Lundbeck, A Menarini Pharma, Bayer, HRA Pharma UK and GlaxoSmithKline named by PMCPA. ... Lundbeck, A Menarini Pharma, Bayer, HRA Pharma UK and GlaxoSmithKline (GSK) were named by the PMCPA – the Code's administrator - in medical, pharmaceutical and

Latest news

  • Clouded vision

    Speciality European Pharma)  . Overactive bladder . UK. Ulipristal acetate. ellaOne (HRA Pharma). ... Emergency contraception . France, Germany, UK. Vinorelbine . Sagent Pharmaceuticals). Advanced non-small cell lung cancer .

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Wordbird tops the leader chart at the OTC awards

    They also supported HRA Pharma UK as they won Most Innovative New OTC Product. ... why our judges gave HRA Pharma’s emergency contraceptive ellaOne  a near-perfect score for this Award.”.

  • Wordbird helps ellaOne® fly over the counter

    Wordbird is delighted to be working with HRA Pharma on their OTC launch of the emergency contraceptive pill, ellaOne. ... Wordbird is also thrilled to announce that its PAGB associate membership has been accepted following its work with HRA Pharma UK and

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

David Atkins
A snapshot of Congenica
PME talks to CEO David Atkins...
Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...

Infographics